The effects of synbiotics on indoxyl sulphate level, constipation, and quality of life associated with constipation in chronic haemodialysis patients: a randomized controlled trial

BACKGROUND: Gut microbiota dysbiosis in patients with chronic kidney disease on haemodialysis (CKD-HD) creates an increase in proteolytic bacteria activity, leading to an increase in the production of uraemic toxins, such as indoxyl sulphate, worsening of constipation symptoms and reducing patients’...

Descripción completa

Detalles Bibliográficos
Autores principales: Lydia, Aida, Indra, Tities Anggraeni, Rizka, Aulia, Abdullah, Murdani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308250/
https://www.ncbi.nlm.nih.gov/pubmed/35869437
http://dx.doi.org/10.1186/s12882-022-02890-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308250/
https://www.ncbi.nlm.nih.gov/pubmed/35869437
http://dx.doi.org/10.1186/s12882-022-02890-9

Ejemplares similares